America Stem Cell, Inc. Awarded a Phase I STTR To Explore The Therapeutic Potential Of Its Platform Technology (ASC-101) With Amniotic Fluid-Derived Stem Cells
SAN ANTONIO, TX SEPTEMBER 17, 2012.
America Stem Cell, Inc (ASC) today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health. This grant will be conducted in collaboration with scientists at the Wake Forest Institute of Regenerative Medicine (WFIRM) in Winston-Salem, NC, and will explore the combination of two technologies: ASC-101 developed by America Stem Cell and amniotic fluid-derived stem cells discovered and pioneered by Dr. Shay Soker and colleagues at WFIRM. We will examine the […]